Variant #0000735290 (NC_000006.11:g.88231191C>T, NM_020320.3:c.1026G>A (RARS2))
| Individual ID |
00334936 |
| Chromosome |
6 |
| Allele |
Paternal (confirmed) |
| Affects function (as reported) |
Effect unknown |
| Affects function (by curator) |
Not classified |
| Classification method |
ACMG |
| Clinical classification |
VUS |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.88231191C>T |
| DNA change (hg38) |
- |
| Published as |
- |
| ISCN |
- |
| DB-ID |
RARS2_000026 See all 5 reported entries |
| Variant remarks |
ACMG PM1, PM2, PP3; The patient's electroclinical phenotype shares some features with previous reports for this gene, namely prominent myoclonus, though later onset (not infantile) and a lack of other associated features is noted. The two ultra-rare predicted damaging variants were confirmed in trans and the parents are not related, consistent with the bi-allelic autosomal recessive inheritance. It is therefore with moderate confidence that we expand the RARS2 phenotype to PME. |
| Reference |
PubMed: Courage 2021, Journal: Courage 2021 |
| ClinVar ID |
- |
| dbSNP ID |
- |
| Origin |
Germline |
| Segregation |
- |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
0.00026 View details |
| Owner |
Carolina Courage |
| Database submission license |
No license selected |
| Created by |
Carolina Courage |
| Date created |
2021-03-02 13:54:29 +01:00 (CET) |
| Date last edited |
2021-04-14 10:21:27 +02:00 (CEST) |

Variant on transcripts
Screenings
|